Literature DB >> 10907109

Autoimmunity in atherosclerosis. The role of autoantigens.

J George1, D Harats, Y Shoenfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10907109     DOI: 10.1385/CRIAI:18:1:73

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


× No keyword cloud information.
  63 in total

Review 1.  The heat-shock proteins.

Authors:  S Lindquist; E A Craig
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

2.  Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation.

Authors:  A N Klimov; A D Denisenko; A V Popov; V A Nagornev; V M Pleskov; A G Vinogradov; T V Denisenko; G M Kheifes; A S Kuznetzov
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162

3.  Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies.

Authors:  J George; A Afek; B Gilburd; Y Levy; M Blank; J Kopolovic; D Harats; Y Shoenfeld
Journal:  Lupus       Date:  1997       Impact factor: 2.911

4.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

Authors:  S D Cushing; J A Berliner; A J Valente; M C Territo; M Navab; F Parhami; R Gerrity; C J Schwartz; A M Fogelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65.

Authors:  Q Xu; H Dietrich; H J Steiner; A M Gown; B Schoel; G Mikuz; S H Kaufmann; G Wick
Journal:  Arterioscler Thromb       Date:  1992-07

Review 6.  Infectious agents and atherosclerotic vascular disease.

Authors:  P J Cook; G Y Lip
Journal:  QJM       Date:  1996-10

7.  Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity.

Authors:  C Karopoulos; M J Rowley; C J Handley; R A Strugnell
Journal:  J Autoimmun       Date:  1995-04       Impact factor: 7.094

8.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.

Authors:  S Freigang; S Hörkkö; E Miller; J L Witztum; W Palinski
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-12       Impact factor: 8.311

10.  Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.

Authors:  G Virella; I Virella; R B Leman; M B Pryor; M F Lopes-Virella
Journal:  Int J Clin Lab Res       Date:  1993
View more
  9 in total

1.  Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Authors:  Aleksandar K Stanic; Charles M Stein; Adam C Morgan; Sergio Fazio; MacRae F Linton; Edward K Wakeland; Nancy J Olsen; Amy S Major
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 2.  Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

Authors:  Kuang-Yuh Chyu; Prediman K Shah
Journal:  Ther Adv Vaccines       Date:  2014-03

3.  Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.

Authors:  H A Schenkein; C R Berry; D Purkall; J A Burmeister; C N Brooks; J G Tew
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 4.  Natural killer T cells and atherosclerosis: form and function meet pathogenesis.

Authors:  Nicole A Braun; Roman Covarrubias; Amy S Major
Journal:  J Innate Immun       Date:  2010-03-17       Impact factor: 7.349

5.  Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease.

Authors:  Petra Bago Rožanković; Arijana Lovrenčić Huzjan; Hrvoje Cupić; Ines Jajić Benčić; Silvio Bašić; Vida Demarin
Journal:  J Neurol       Date:  2010-11-18       Impact factor: 4.849

6.  The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.

Authors:  N S Wade; B G Stevenson; D S Dunlap; A S Major
Journal:  Lupus       Date:  2009-10-22       Impact factor: 2.911

7.  Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.

Authors:  Ashley J Wilhelm; Jillian P Rhoads; Nekeithia S Wade; Amy S Major
Journal:  Ann Rheum Dis       Date:  2014-01-06       Impact factor: 19.103

8.  CagA+ Helicobacter pylori, Not CagA- Helicobacter pylori, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation.

Authors:  Xiujuan Xia; Linfang Zhang; Hao Wu; Feng Chen; Xuanyou Liu; Huifang Xu; Yuqi Cui; Qiang Zhu; Meifang Wang; Hong Hao; De-Pei Li; William P Fay; Luis A Martinez-Lemus; Michael A Hill; Canxia Xu; Zhenguo Liu
Journal:  Front Cardiovasc Med       Date:  2022-03-31

9.  Exosome-Transmitted miR-25 Induced by H. pylori Promotes Vascular Endothelial Cell Injury by Targeting KLF2.

Authors:  Na Li; Shi-Feng Liu; Kai Dong; Gui-Chun Zhang; Jing Huang; Zhi-Heng Wang; Tong-Jian Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-10-29       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.